Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year

Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year

Bibliografiset tiedot
Päätekijät: Merola, JF, Li, S, Hsu, M-C, Karyekar, C, Gorecki, PC, Flavin, S, Randazzo, B, Coates, LC
Aineistotyyppi: Conference item
Kieli:English
Julkaistu: Oxford University Press 2020

Samankaltaisia teoksia